Retrophin (RTRX) Tops Q2 EPS by 16c

Go back to Retrophin (RTRX) Tops Q2 EPS by 16c

Retrophin Reports Second Quarter 2016 Financial Results

August 4, 2016 4:02 PM EDT

Second quarter revenues increased 38 percent year-over-year

Sparsentan top-line data expected in third quarter of 2016

RE-024 efficacy trial expected to initiate in second half of 2016

SAN DIEGO, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today reported its second quarter 2016 financial results.

Net product sales for the second quarter of 2016 were $33.3 million, compared to net product sales of $24.1 million for the same period in 2015Cash, cash equivalents, marketable securities, and notes receivable as of June 30,... More